The role of FDG-PET/CT in gynaecological cancers

There is now a growing body of evidence supporting the use of fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in gynaecological malignancies. Although this molecular imaging technique is becoming increasingly available, PET/CT remains an expensive imaging tool. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Rockall, Andrea G, Cross, Susan, Flanagan, Sean, Moore, Elizabeth, Avril, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: e-Med 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335332/
https://www.ncbi.nlm.nih.gov/pubmed/22391444
http://dx.doi.org/10.1102/1470-7330.2012.0007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335332/
https://www.ncbi.nlm.nih.gov/pubmed/22391444
http://dx.doi.org/10.1102/1470-7330.2012.0007

Ejemplares similares